GB0820884D0 - Suppression of neuroendocrine diseases - Google Patents

Suppression of neuroendocrine diseases

Info

Publication number
GB0820884D0
GB0820884D0 GB0820884A GB0820884A GB0820884D0 GB 0820884 D0 GB0820884 D0 GB 0820884D0 GB 0820884 A GB0820884 A GB 0820884A GB 0820884 A GB0820884 A GB 0820884A GB 0820884 D0 GB0820884 D0 GB 0820884D0
Authority
GB
United Kingdom
Prior art keywords
suppression
neuroendocrine diseases
neuroendocrine
diseases
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GB0820884A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Syntaxin Ltd
Original Assignee
Syntaxin Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Syntaxin Ltd filed Critical Syntaxin Ltd
Priority to GB0820884A priority Critical patent/GB0820884D0/en
Publication of GB0820884D0 publication Critical patent/GB0820884D0/en
Priority to CN200980130069.3A priority patent/CN102112145B/en
Priority to AU2009259033A priority patent/AU2009259033B2/en
Priority to EP19175007.4A priority patent/EP3590956A1/en
Priority to EP09762018.1A priority patent/EP2310028B1/en
Priority to US12/996,643 priority patent/US20110171191A1/en
Priority to EP13179177.4A priority patent/EP2719392B1/en
Priority to CA2727082A priority patent/CA2727082C/en
Priority to CN201410295607.7A priority patent/CN104328100B/en
Priority to ES09762018.1T priority patent/ES2614990T3/en
Priority to BRC10915888A priority patent/BRPI0915888E2/en
Priority to JP2011513056A priority patent/JP5728380B2/en
Priority to KR1020117000251A priority patent/KR101642363B1/en
Priority to ES13179177T priority patent/ES2750651T3/en
Priority to PCT/GB2009/050665 priority patent/WO2009150469A2/en
Priority to ZA2010/08536A priority patent/ZA201008536B/en
Priority to IL209855A priority patent/IL209855A/en
Priority to US12/969,810 priority patent/US8796216B2/en
Priority to US14/250,959 priority patent/US20140302006A1/en
Priority to JP2014087047A priority patent/JP5891258B2/en
Ceased legal-status Critical Current

Links

GB0820884A 2008-06-12 2008-11-14 Suppression of neuroendocrine diseases Ceased GB0820884D0 (en)

Priority Applications (20)

Application Number Priority Date Filing Date Title
GB0820884A GB0820884D0 (en) 2008-11-14 2008-11-14 Suppression of neuroendocrine diseases
PCT/GB2009/050665 WO2009150469A2 (en) 2008-06-12 2009-06-11 Suppression of neuroendocrine diseases
CN201410295607.7A CN104328100B (en) 2008-06-12 2009-06-11 The inhibition of neuroendocrine disease
BRC10915888A BRPI0915888E2 (en) 2008-06-12 2009-06-11 polypeptide, its activation method, nucleic acid sequence encoding it and its use
EP19175007.4A EP3590956A1 (en) 2008-06-12 2009-06-11 Suppression of neuroendocrine diseases
EP09762018.1A EP2310028B1 (en) 2008-06-12 2009-06-11 Fusion proteins for use in the treatment of acromegaly
US12/996,643 US20110171191A1 (en) 2008-06-12 2009-06-11 Suppression of neuroendocrine diseases
EP13179177.4A EP2719392B1 (en) 2008-06-12 2009-06-11 Fusion proteins for use in the treatment of acromegaly
CA2727082A CA2727082C (en) 2008-06-12 2009-06-11 Fusion proteins for use in suppression of acromegaly
CN200980130069.3A CN102112145B (en) 2008-06-12 2009-06-11 Suppression of neuroendocrine diseases
ES09762018.1T ES2614990T3 (en) 2008-06-12 2009-06-11 Fusion proteins for use in the treatment of acromegaly
AU2009259033A AU2009259033B2 (en) 2008-06-12 2009-06-11 Suppression of neuroendocrine diseases
JP2011513056A JP5728380B2 (en) 2008-06-12 2009-06-11 Suppression of neuroendocrine disease
KR1020117000251A KR101642363B1 (en) 2008-06-12 2009-06-11 Suppression of neuroendocrine diseases
ES13179177T ES2750651T3 (en) 2008-06-12 2009-06-11 Fusion proteins for use in the treatment of acromegaly
ZA2010/08536A ZA201008536B (en) 2008-06-12 2010-11-29 Suppression of neuroendocrine diseases
IL209855A IL209855A (en) 2008-06-12 2010-12-08 Polypeptide, nucleic acid sequence encoding such a polypeptide and the use of such a polypeptide in the preparation of a medicament for treating acromegaly
US12/969,810 US8796216B2 (en) 2008-06-12 2010-12-16 Suppression of neuroendocrine diseases
US14/250,959 US20140302006A1 (en) 2008-06-12 2014-04-11 Suppression of neuroendocrine diseases
JP2014087047A JP5891258B2 (en) 2008-06-12 2014-04-21 Suppression of neuroendocrine disease

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB0820884A GB0820884D0 (en) 2008-11-14 2008-11-14 Suppression of neuroendocrine diseases

Publications (1)

Publication Number Publication Date
GB0820884D0 true GB0820884D0 (en) 2008-12-24

Family

ID=40194662

Family Applications (1)

Application Number Title Priority Date Filing Date
GB0820884A Ceased GB0820884D0 (en) 2008-06-12 2008-11-14 Suppression of neuroendocrine diseases

Country Status (1)

Country Link
GB (1) GB0820884D0 (en)

Similar Documents

Publication Publication Date Title
ZA201008536B (en) Suppression of neuroendocrine diseases
HK1246809A1 (en) Suppression of cancers
HK1245114A1 (en) Suppression of cancer
GB2473392B (en) Methods of diagnosis
IL208354A0 (en) Methods of treatment
EP2331089A4 (en) Uses of sesquiterpene derivatives
ZA201102604B (en) Alkylcyclohexylethers of dihydrotetraazabenzoazulenes
PL2133419T3 (en) Uses of cyanophycin beta-dipeptides
HK1160925A1 (en) Use of athepsin
HK1156250A1 (en) Unit dosage of apadenoson
ZA201004979B (en) Extracts of sclerocarya birrea
HK1173139A1 (en) Fluorinated derivatives of 3-hydroxypyridin-4-ones 3--4-
EP2331490A4 (en) Preparation of dibutoxymethane
GB0820884D0 (en) Suppression of neuroendocrine diseases
GB0810785D0 (en) Suppression of neuroendocrine diseases
PL386302A1 (en) New derivative of isothiazolopyridine
GB0811560D0 (en) Suppression of hypertension
GB0820965D0 (en) Suppression of cancers
GB0810782D0 (en) Suppression of cancers
AU2013257527A1 (en) Unit dosage of apadenoson
GB0821710D0 (en) Derivatives of dihydroindolone
GB0910052D0 (en) Suppression of hypertension
HU0800656D0 (en) Effective use of tea-composition
ZA201104656B (en) Suppression of neuroendocrine diseases
IL207009A0 (en) Extracts of sclerocarya birrea

Legal Events

Date Code Title Description
AT Applications terminated before publication under section 16(1)